60 DEGREES PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $21.52 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Notes › Debt and Equity Securities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2024-05-15
- 2024-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.52M.
- 2023-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.52M.
- 2023-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.52M.
- 2023-01-09: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.52M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2024-03-31 | $21.52M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $21.52M 10-K · filed 2024-04-01 |
| 2023-03-31 | $21.52M 10-Q · filed 2023-11-20 |
| 2023-01-09 | $21.52M 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |